Smith & Nephew Snats ADR (SNN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SNN | ABT | SYK | MDT | BSX |
| Company | Smith & Nephew Snats ADR | Abbott Laboratories | Stryker Corp | Medtronic Inc | Boston Scientific Corp |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NYSE | NYSE |
| Open | 24.53 | 106.51 | 335.19 | 79.40 | 72.88 |
| High | 24.62 | 107.86 | 338.51 | 79.85 | 73.61 |
| Low | 24.33 | 106.39 | 334.44 | 78.95 | 72.64 |
| Last | 24.45 | 107.53 | 335.61 | 79.74 | 73.17 |
| Change | +0.57 | +0.67 | -1.54 | +0.49 | -0.09 |
| % Change | +2.39% | +0.63% | -0.46% | +0.62% | -0.12% |
| Volume | 1,759,800 | 3,575,500 | 1,063,700 | 5,024,800 | 8,786,200 |
| 20-Day Average Volume | 1,009,970 | 5,398,030 | 1,161,570 | 6,032,410 | 6,665,185 |
| Previous Close | 23.88 | 106.86 | 337.15 | 79.25 | 73.26 |
| Industry | Medical Products | Medical Products | Medical Products | Medical Products | Medical Products |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 24.27 | 109.19 | 341.38 | 81.78 | 68.88 |
| 20-Day Raw Stochastic | 66.12% | 34.86% | 35.51% | 14.97% | 83.93% |
| 20-Day Relative Strength | 43.63% | 41.33% | 43.87% | 40.31% | 71.49% |
| Weighted Alpha | -23.67 | -1.61 | +15.58 | -10.73 | +49.29 |
| Today's Opinion | 56% Sell | 8% Buy | 40% Buy | 40% Sell | 100% Buy |
| Previous Opinion | 72% Sell | 8% Sell | 40% Buy | 40% Sell | 100% Buy |
| Last Month's Opinion | 24% Sell | 56% Buy | 100% Buy | 80% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.56% since 04/19/24 | +0.23% since 04/19/24 | +3.13% since 04/19/24 | +0.33% since 04/19/24 | +8.67% since 04/19/24 |
| Low | 23.86 on 04/25/24 | 105.56 on 04/24/24 | 323.75 on 04/22/24 | 78.78 on 04/25/24 | 66.80 on 04/22/24 |
| High | 24.82 on 04/23/24 | 108.11 on 04/23/24 | 342.60 on 04/24/24 | 81.34 on 04/23/24 | 74.39 on 04/24/24 |
| 1-Month | |||||
| %Chg | -6.25% since 03/26/24 | -3.56% since 03/26/24 | -4.22% since 03/26/24 | -4.73% since 03/26/24 | +7.70% since 03/26/24 |
| Low | 23.65 on 04/16/24 | 104.25 on 04/17/24 | 323.75 on 04/22/24 | 78.43 on 04/18/24 | 66.80 on 04/22/24 |
| High | 26.52 on 03/27/24 | 114.02 on 03/28/24 | 359.50 on 03/28/24 | 87.73 on 03/28/24 | 74.39 on 04/24/24 |
| 3-Month | |||||
| %Chg | -12.87% since 01/26/24 | -4.00% since 01/26/24 | +7.79% since 01/26/24 | -7.86% since 01/26/24 | +19.70% since 01/26/24 |
| Low | 23.65 on 04/16/24 | 104.25 on 04/17/24 | 310.74 on 01/29/24 | 78.43 on 04/18/24 | 60.78 on 01/29/24 |
| High | 28.93 on 02/22/24 | 121.64 on 03/08/24 | 361.41 on 03/11/24 | 89.18 on 01/31/24 | 74.39 on 04/24/24 |
| 6-Month | |||||
| %Chg | +13.46% since 10/26/23 | +14.42% since 10/26/23 | +29.79% since 10/26/23 | +13.32% since 10/26/23 | +46.99% since 10/26/23 |
| Low | 21.52 on 10/27/23 | 91.64 on 10/30/23 | 257.98 on 10/27/23 | 68.84 on 10/30/23 | 49.15 on 10/27/23 |
| High | 28.93 on 02/22/24 | 121.64 on 03/08/24 | 361.41 on 03/11/24 | 89.18 on 01/31/24 | 74.39 on 04/24/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 10,688,734 | 186,584,320 | 127,689,528 | 105,880,600 | 107,347,408 |
| Shares Outstanding, K | 437,167 | 1,735,184 | 380,470 | 1,327,823 | 1,467,096 |
| Annual Sales | 5,549,000,000 | 40,109,000,000 | 20,498,000,000 | 31,227,000,000 | 14,240,000,000 |
| Annual Net Income | 263,000,000 | 5,723,000,000 | 3,165,000,000 | 3,758,000,000 | 1,591,000,000 |
| Last Quarter Sales | 1,249,000,000 | 9,964,000,000 | 5,815,000,000 | 8,089,000,000 | 3,725,000,000 |
| Last Quarter Net Income | 160,000,000 | 1,225,000,000 | 1,143,000,000 | 1,322,000,000 | 503,000,000 |
| 60-Month Beta | 0.73 | 0.74 | 0.89 | 0.76 | 0.78 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.98 on 04/17/24 | 3.46 on 01/30/24 | 1.30 on 02/20/24 | 0.56 on 04/24/24 |
| Latest Earnings Date | 02/27/24 | 04/17/24 | 04/30/24 | 05/23/24 | 04/24/24 |
| Most Recent Dividend | 0.452 on 04/01/24 | 0.550 on 04/12/24 | 0.800 on 03/27/24 | 0.690 on 03/21/24 | N/A |
| Next Ex-Dividends Date | 04/01/24 | 04/12/24 | 03/27/24 | 03/21/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 24.34 | 31.81 | 14.90 | 34.23 |